Company / Corporate
Supernus.
Follow SupernusSupernus Pharmaceuticals, Inc. is a Delaware corporation and parent in the tender offer for Sage Therapeutics.[1]
01Deal
Deals on Carrywatch
Every deal that names Supernus, and its role in each.
Supernus / Sage
Supernus and Sage enter into a merger agreement
See deal detailsDeal Web
Supernus and 1 firm it shares a posted deal with, and the path to any other firm.
Financials
2 fiscal years of figures as Supernus reported them.
News
Loading headlines.
Sources
As of 25 Oct 2026.
- 01SC 14D9 — Sage Therapeutics, Inc.
U.S. Securities and Exchange Commission · Researched 25 Oct 2026
Deal posts naming Supernus:
- P01Sage Therapeutics, Inc.: Supernus / Sage
13 Jun 2025